English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/81325
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Inhibition of proliferation and induction of apoptosis in human breast cancer cells by lauryl gallate

AuthorsCalcabrini, Annarica ; García-Martínez, José Manuel ; González, Lorena; Julián-Tendero, Mercedes; Agulló-Ortuño, María Teresa ; López-Rivas, Abelardo ; González-Porque, Pedro; Martín-Pérez, Jorge
Issue Date2006
PublisherOxford University Press
CitationCarcinogenesis 27(8): 1699-1712 (2006)
AbstractLauryl gallate is an antioxidant food additive showing low toxicity to normal cells. Here, its antiproliferative effect has been studied on three human breast cancer cell lines: estrogen-dependent, wild-type p53, MCF7; estrogen-independent, non-functional p53, MDA-MB-231 and MCF7 ADR, which overexpresses P-glycoprotein (P-gp) and displays a multidrug-resistant phenotype. Lauryl gallate inhibited proliferation and induced cell cycle alterations in all three cell lines without altering P-gp functionality in the drug-resistant cells. A stable arrest in G1 phase was observed in MCF7, while a slow-down of cell cycle progression was induced in the other two cell lines. Lauryl gallate increased p53 expression only in MCF7, and upregulated p21Cip1 and reduced cyclin D1 levels in all three cell lines. The induction of apoptosis, demonstrated by annexin V-FITC labeling, PARP cleavage and mitochondrial membrane depolarization and morphological alterations, were clearly detected in MCF7 ADR and MDA-MB-231 and to a minor extent in MCF7. Overexpression of Bcl-2 in MCF7 ADR cells demonstrated its protective role against morphological alterations and apoptosis. Lauryl gallate induction of p21Cip1 and apoptosis observed in all three cell lines was regulated by Erk1/2 activation. These findings suggest a potential use of lauryl gallate against tumors harboring p53 mutations and drug-resistant phenotypes. © 2006 Oxford University Press.
URIhttp://hdl.handle.net/10261/81325
DOI10.1093/carcin/bgl044
Identifiersdoi: 10.1093/carcin/bgl044
issn: 0143-3334
e-issn: 1460-2180
Appears in Collections:(CABD) Artículos
(IIBM) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.